Figure 2.
Comparison between high- and low-frequency subgroups for symptoms of gastroesophageal reflux disease (FSSG) scores (±standard error) in the rivastigmine patch (18 mg) with domperidone (30 mg) (RWD) and rivastigmine patch (18 mg) without domperidone (RWOD) groups.
Note: #P < 0.05 versus baseline.